Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies

By sjmartinez • March 24, 2024

Armstrong A, González-Cantero A, Khattri S, Muzy G, Malatestinic WN, Lampropoulou A, Feely M, See SK, Mert C, Blauvelt A. Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies. Dermatol Ther (Heidelb). 2024 Mar 23. doi: 10.1007/s13555-024-01136-w. Epub ahead of print. PMID: 38521874.

Tags: Biologics, Body surface area, Dermatology, Head-to-head, ixekizumab, national psoriasis foundation, plaque psoriasis, Publications, Real world, Treat-to-target, Treatment goals

Correction for Hirsch et al., “Complete genome of Variovorax sp. EBFNA2, isolated from a surface-sterilized fava bean nodule”

Hirsch AM, Youseif SH, Humm E, Rubbi L, Del Vecchio G, Ha SM, Pellegrini M, Gunsalus RP. Correction for Hirsch et al., "Complete genome of Variovorax sp.[...]

Genomes of Syntrophomonas erecta GB4-38T and Syntrophomonas erecta subsp. sporosyntropha 5-3-ZT that degrade C4-8 short-chain fatty acids

Ha SM, Humm E, Wofford NQ, Sieber JR, Rubbi L, Del Vecchio G, Pellegrini M, McInerney MJ, Gunsalus RP. Genomes of Syntrophomonas erecta GB4-38T and Syntrophomonas erecta subsp. sporosyntropha 5-3-ZT that degrade C4-8[...]

Live imaging of vascular dynamics in mouse skin

Song I, Blumberg MA, Kam CY. Live imaging of vascular dynamics in mouse skin. J Invest Dermatol. 2026 Feb 12:S0022-202X(26)00024-2. doi: 10.1016/j.jid.2025.12.031. Epub ahead of[...]